#Mushrooms on the
Brain: (OTC: $LRSV) (OTC: $MMEDF) (OTC: $TRMNF), (TSXV: $PSYB.V) (OTC: $TRUFF) @res_pet @mindmedco
@NewWaveHolding @PSYBioLife @redlightholland
Functional and #Psychedelic
Mushrooms Continue to Dominate #Health and #Medical Trends
Point
Roberts WA, Delta, BC – April 16, 2021 - Investorideas.com, a
leading investor news resource covering functional mushrooms and plant-based
food alternatives releases a special report on the growing dominance of both
functional and psychedelic mushrooms in the current health and wellness sector,
featuring Link Reservations Inc. (OTC:
LRSV). Current medicinal
trends and new research point to the phenomenal promise of fungi for the future
of food, medicine and technology.
Read this news,
featuring LRSV in full at https://www.investorideas.com/news/2021/lohas/04161LRSV-Psychedelic-Mushrooms.asp
Looking
at just one single mushroom, Reishi, is used in many modern health and wellness
products, according to Allied
Market Research, “The global reishi mushroom market was
valued at $3,096.9 million in 2019, and is projected to reach $5,059.4 million
by 2027, registering a CAGR of 8.1% from 2021 to 2027. In 2019, the powder
reishi mushroom segment accounted for the highest share in the reishi mushroom
market size.”
Link
Reservations Inc. (OTC:
LRSV), a provider of wellness and cannabidiol (CBD) products
for both humans and pets just recently announced the
launch and availability to purchase DailyLife
CBD Immune, its immune boosting functional mushroom product. Featuring a
combination of CBD and a spectrum of functional mushrooms (including Lion’s
Mane), the tincture will be available for sale on the DailyLife CBD website.
“It is my pleasure
to announce that we have now launched our first functional mushroom product. We
have been researching the power of medicinal mushrooms for some time and it is
great to be able to bring to market a product that combines the power of
mushrooms with the anti-inflammatory benefits of CBD. The overall goal is to
offer natural products that can strongly benefit our health and, with regards
to DailyLife CBD Immune, to boost and maintain a healthy immune system,”
commented Rene Lauritsen, CEO at Link Reservations Inc. “Health and wellbeing
have been absolutely front of mind for everyone in the past 12 months, so
creating a product that can naturally benefit people is a great achievement,” he
added.
DailyLife CBD Immune
features an organic blend of 13 different medicinal mushrooms, including Lions
Mane, Turkey Tail, Chaga, Red Reishi, Cordyceps amongst others. By focusing on
a variety of mushrooms, the product is able to encompass multiple immune boosting
traits and benefits. In addition, DailyLife CBD Immune also includes 250mg of
hemp oil CBD extract and 100mg of vitamin C which will add to the immune
boosting benefits.
“We are excited
with the first launch of the functional mushroom range and we look forward to
see the reception while we work on the other projects in the pipeline. We look
forward to sharing more developments as they arise through press releases,”
ended Lauritsen.
Link Reservations isn’t
alone in pivoting off CBD wellness products into the functional mushroom
category as NEW WAVE HOLDINGS CORP. (CSE:
SPOR) (OTC:
TRMNF), an investment issuer that provides capital and
support services recently
announced the launch of its first mushroom products in a new
functional mushroom collection, which will live under the Way of Will brand.
Way of
Will, a natural wellness brand under New Wave and known for its
aromatherapy-based products, revealed earlier this year that it will be introducing
a new line of functional mushroom products in the upcoming months. Further to
the announcement, the company is releasing the Functional Mushroom Powder and
the Functional Mushroom Capsules from the collection to the U.S. market. Paving
the way to a larger collection of specialty mushroom products, the mushroom
powder and capsules will be the first step in Way of Will's journey into the
psychedelics space.
The
product launch, featuring a house-blend of five functional mushrooms and fungi
available in both capsule and powder format, aim to naturally boost immunity.
They are loaded with vitamins, nutrients, and antioxidants that support a
healthy immune system. The capsules are designed with ease of consumption and
convenience in mind, while the powder allows for versatile use by mixing and
incorporating it into foods and beverages.
"Mushrooms
are gaining popularity rapidly right now, but they're not a new phenomenon in
food and medicine. They have been used in certain regions of the world for
centuries for a plethora of health and wellness purposes," said Willie
Tsang, founder and CEO of Way of Will.
Goldman
Small Cap Research, a stock market research firm specializing in the small cap
and microcap sectors, recently announced that it has published a new research
report on Link Reservations, Inc. (OTC PINK:LRSV).. This report carries a
price target of 10 .
Looking at the
psychedelic mushroom space, which has been mostly dominated by news on
psilocybin, we are now just beginning to see growing interest in compounds
other than psilocin in psychoactive mushroom strains. PsyBio Therapeutics Corp. (TSXV:
PSYB), a biotechnology company developing novel
formulations of psychoactive medications produced by genetically modified
bacteria for the treatment of mental health and other disorders and a leader in
the field of psychedelic research and drug development, has
initiated process development of its proprietary
biosynthetic formulation of norbaeocystin in collaboration with the Advanced
Biofuels and Bioproducts Process Development Unit, a scale-up facility managed
by Lawrence Berkeley National Laboratory, a US Department of Energy national
laboratory. Norbaeocystin is an analogue of psilocybin and is not a controlled
substance. The Company has commenced Phase I of this process, including
analytical chemistry technical transfer to establish detection methods for
fermentation products and key feedstocks and metabolites.
As both
functional and psychoactive mushrooms continue to grow in popularity, much as
we have seen in the cannabis industry, infrastructure and supply chains are the
next hurdle the mushroom industry must look to address. Red Light Holland Corp. (CSE:
TRIP) (OTC:
TRUFF), an Ontario-based
corporation engaged in the production, growth and sale of a premium brand of
magic truffles to the legal, recreational market within the Netherlands, recently
announced that its
wholly-owned subsidiary, RLH Netherlands B.V., has completed the acquisition of
SR Wholesale B.V., one of the
Netherlands' premiere distributors for quality psychedelic truffles. In 2020,
SR Wholesale generated over $2.44 Million in revenues[1], and over $822,0001 in
gross profit, with approximately $400,0001 of cash and working capital
currently on hand. SR Wholesale also distributes popular CBD products, cannabis
seeds, smart shop items, and headshop products, among others. SR Wholesale has
established a distribution network of over 400 companies that sell their
products across Europe, including working with sub-distributors which provide
products to over 1,000 shops in countries like the Netherlands, Germany, Spain,
Czech, Greece, UK, France, and Portugal.
Founded
in 2017, SR Wholesale has grown to become one of the most recognized and
trusted distribution companies in the Netherlands. In connection with the
Acquisition, Red Light Holland announced that Mr. Shai Ramsahai, Founder of SR
Wholesale, has joined the Red Light Holland team on closing as Vice-President
to oversee the integration of SR Wholesale into the Red Light Holland ecosystem,
and grow the distribution business for Red Light Holland globally. The
acquisition will create immediate synergies and enhance Red Light Holland's
growth and expansion strategy.
"The
acquisition of SR Wholesale marks the latest step in the Company's growth and
expansion strategy, as we continue to move forward with a positive business
outlook focused on achieving revenue growth, profitability and value creation
for our shareholders. We expect this transaction to serve as a launchpad for
Red Light Holland to broaden operations, create new homes for our iMicrodose
packs and build brand exposure into multiple European markets. Others companies
in the sector can keep telling people or assuming how people should consume
psilocybin years from now, while we will continue offering people what they
want right now, while concentrating on immediate revenue, profit and
growth" said Todd Shapiro, Chief Executive Officer and Director of the
Company. "We are quite thrilled, after months of tough negotiations and
careful due diligence, to move forward as the largest legal psychedelic
distribution publicly traded company in the world.[2] As well, we are truly so
pleased to work closely with Mr. Shai Ramsahai, who is one of the brightest,
most determined and likeable entrepreneurs I've ever come across. And he is an
absolute legend in the Netherlands!"
Other companies in
the psychedelic mushroom sector include MindMed (OTC: MMEDF), a
clinical-stage psychedelic medicine biotech company that discovers, develops
and deploys psychedelic inspired medicines and therapies to address addiction
and mental illness. The company is assembling a
drug development pipeline of innovative treatments based on psychedelic
substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative,
18-MC. The Company is expanding its reach in psychedelic research and recently announced,”
MindMed Announces the Publication of New Data on Personalized MDMA Dosing.”
According
to Fortune
Business Insights, “The global
mushroom market was valued at 12.74 million tons (MT) in 2018 and is projected
to reach 20.84 million tons (MT) by 2026, exhibiting a CAGR of 6.41% in the
forecast period.”
As new research and developments provide mounting
evidence supporting the use of functional and psychedelic mushrooms as sustainable,
healthy medical and food alternatives, it seems the fantastic world of fungi
will be the topic of much discussion for years to come.
About
Investorideas.com - Investorideas.com is a recognized news
source publishing third party news, research and original financial content.
Learn about investing in stocks and sector trends with our news alerts,
articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI Eye
Disclaimer/Disclosure
:Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
management and IR of each company directly regarding specific questions. Disclosure:
this news article featuring LRSV is a paid for news release on Investorideas.com
– third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact
Investorideas.com
800-665-0411
Health, Wellness and Sustainability Stocks Research and News at
Investorideas.com - investing ideas for a better world
Like Health, Wellness and Sustainability Stocks? View our
Get more Cannabis Stock
Investor Ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment